Peiying Ye

747 total citations
16 papers, 515 citations indexed

About

Peiying Ye is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Peiying Ye has authored 16 papers receiving a total of 515 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 5 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Peiying Ye's work include CAR-T cell therapy research (3 papers), Immunotherapy and Immune Responses (3 papers) and T-cell and B-cell Immunology (3 papers). Peiying Ye is often cited by papers focused on CAR-T cell therapy research (3 papers), Immunotherapy and Immune Responses (3 papers) and T-cell and B-cell Immunology (3 papers). Peiying Ye collaborates with scholars based in China, United States and Switzerland. Peiying Ye's co-authors include Pan Zheng, Yang Liu, Peng Zhang, Fei Tang, Martin Devenport, Xuexiang Du, Xu Wang, Juanjuan Su, Wei Wu and Yan Zhang and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and Molecular Cell.

In The Last Decade

Peiying Ye

15 papers receiving 504 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peiying Ye China 9 275 256 180 71 35 16 515
Junya Ohtake Japan 10 296 1.1× 276 1.1× 192 1.1× 68 1.0× 54 1.5× 18 524
Janina Dörr Germany 2 253 0.9× 263 1.0× 177 1.0× 59 0.8× 49 1.4× 2 530
Naoshi Kawamura Japan 10 233 0.8× 204 0.8× 156 0.9× 57 0.8× 46 1.3× 12 456
Ravindra Uppaluri United States 10 313 1.1× 390 1.5× 159 0.9× 62 0.9× 44 1.3× 25 590
Christie Fanton United States 11 288 1.0× 267 1.0× 198 1.1× 36 0.5× 32 0.9× 26 587
Jeanne Galaine France 12 298 1.1× 303 1.2× 158 0.9× 58 0.8× 51 1.5× 28 512
Ana Vuletić Serbia 16 308 1.1× 559 2.2× 143 0.8× 51 0.7× 57 1.6× 39 770
Caroline Imbert France 7 278 1.0× 268 1.0× 126 0.7× 39 0.5× 31 0.9× 19 468
Marco Macagno Italy 12 260 0.9× 291 1.1× 180 1.0× 97 1.4× 52 1.5× 15 532
Gabriela Turcu Romania 10 288 1.0× 174 0.7× 117 0.7× 57 0.8× 74 2.1× 26 463

Countries citing papers authored by Peiying Ye

Since Specialization
Citations

This map shows the geographic impact of Peiying Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peiying Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peiying Ye more than expected).

Fields of papers citing papers by Peiying Ye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peiying Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peiying Ye. The network helps show where Peiying Ye may publish in the future.

Co-authorship network of co-authors of Peiying Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Peiying Ye. A scholar is included among the top collaborators of Peiying Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peiying Ye. Peiying Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Ye, Peiying, Jenna Bergerson, Isaac Brownell, et al.. (2025). Resolution of Squamous-Cell Carcinoma by Restoring T-Cell Receptor Signaling. New England Journal of Medicine. 393(5). 469–478.
2.
Li, Jing, Peiying Ye, Yun You, et al.. (2023). A retrospective observational study on maternal and neonatal outcomes of COVID-19: Does the mild SARS-CoV-2 infection affect the outcome?. PeerJ. 11. e16651–e16651. 2 indexed citations
3.
Ye, Peiying, et al.. (2023). Barriers to green human resources management (GHRM) implementation in developing countries: evidence from China. Environmental Science and Pollution Research. 30(44). 99570–99583. 3 indexed citations
4.
Chen, Liwei, et al.. (2023). Adverse drug reactions of non-statin antihyperlipidaemic drugs in China from 1989 to 2019: a national database analysis. BMJ Open. 13(5). e068915–e068915. 9 indexed citations
5.
Ye, Peiying, et al.. (2022). Adverse drug reactions of statin therapy in China from 1989 to 2019: a national database analysis. European Journal of Hospital Pharmacy. 30(e1). e82–e89. 9 indexed citations
6.
Rocco, Joseph M., Mariantonietta Di Stefano, Irini Sereti, et al.. (2022). Impact of Innate Immunity, Endothelial Damage, and Metabolic Biomarkers on COVID-19 Severity and Mortality. Open Forum Infectious Diseases. 9(9). ofac427–ofac427. 2 indexed citations
7.
Flores, Rhonda, Peng Zhang, Wei Wu, et al.. (2018). Siglec genes confer resistance to systemic lupus erythematosus in humans and mice. Cellular and Molecular Immunology. 16(2). 154–164. 20 indexed citations
8.
Liu, Ying, Peiying Ye, Peishuang Du, et al.. (2018). CD24–p53 axis suppresses diethylnitrosamine-induced hepatocellular carcinogenesis by sustaining intrahepatic macrophages. Cell Discovery. 4(1). 6–6. 16 indexed citations
9.
Du, Xuexiang, Mingyue Liu, Juanjuan Su, et al.. (2018). Uncoupling therapeutic from immunotherapy-related adverse effects for safer and effective anti-CTLA-4 antibodies in CTLA4 humanized mice. Cell Research. 28(4). 433–447. 95 indexed citations
10.
Du, Xuexiang, Fei Tang, Mingyue Liu, et al.. (2018). A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy. Cell Research. 28(4). 416–432. 184 indexed citations
11.
Tang, Fei, Peng Zhang, Peiying Ye, et al.. (2017). A population of innate myelolymphoblastoid effector cell expanded by inactivation of mTOR complex 1 in mice. eLife. 6. 5 indexed citations
12.
Ye, Peiying, Yu Liu, Chong Chen, et al.. (2016). Abstract B21: An mTORC1-Mdm2-Drosha axis for miRNA biogenesis in response to glucose- and amino acid-deprivation. Molecular Cancer Research. 14(1_Supplement). B21–B21. 1 indexed citations
13.
Wang, Lizhong, Runhua Liu, Peiying Ye, et al.. (2015). Intracellular CD24 disrupts the ARF–NPM interaction and enables mutational and viral oncogene-mediated p53 inactivation. Nature Communications. 6(1). 5909–5909. 58 indexed citations
14.
Ye, Peiying, Yu Liu, Chong Chen, et al.. (2015). An mTORC1-Mdm2-Drosha Axis for miRNA Biogenesis in Response to Glucose- and Amino Acid-Deprivation. Molecular Cell. 57(4). 708–720. 69 indexed citations
15.
Han, Xue, Peiying Ye, Liqun Luo, et al.. (2011). The development and functions of CD4+ T cells expressing a transgenic TCR specific for an MHC-I-restricted tumor antigenic epitope. Cellular and Molecular Immunology. 8(4). 333–340. 2 indexed citations
16.
Ye, Peiying, Shufeng Liu, Yiping Zhu, Guifang Chen, & Guangxia Gao. (2010). DEXH-Box protein DHX30 is required for optimal function of the zinc-finger antiviral protein. Protein & Cell. 1(10). 956–964. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026